K. A. Selting

Serum Alpha 1-Acid Glycoprotein Concentrations in Healthy and Tumor-Bearing Cats

G. Ogilvie, M. J. Fettman, S. Lana, 2000 .

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.

C. Khanna, C. London, D. Vail, 2010, Veterinary and comparative oncology.

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

C. London, D. Vail, I. Kurzman, 2012, Veterinary and comparative oncology.

Immunohistochemical detection of retinoid receptors in tumors from 30 dogs diagnosed with cutaneous lymphoma.

M. Kiupel, V. Valli, B. Kitchell, 2010, Journal of veterinary internal medicine.

Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia

M. Aherne, Jessica R. Newton-Northup, B. Flesner, 2023, Journal of veterinary internal medicine.

Cardiac troponin I in canine patients with lymphoma and osteosarcoma receiving doxorubicin: comparison with clinical heart disease in a retrospective analysis.

G. Ogilvie, M. J. Fettman, S. Lana, 2004, Veterinary and comparative oncology.

Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.

C. Sharp, K. Selting, J. Knouse, 2015, Veterinary and comparative oncology.